Source: Biomedicine & Pharmacotherapy. Unidade: EEFE
Subjects: RATOS WISTAR, ENDOTÉLIO VASCULAR, INFLAMAÇÃO, DOENÇAS VASCULARES
ABNT
OLIVEIRA, Bruna Coelho de et al. Dipeptidyl peptidase-4 inhibition prevents vascular dysfunction induced by β-adrenergic hyperactivity. Biomedicine & Pharmacotherapy, v. 113, p. 7 , 2019Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2019.108733. Acesso em: 21 out. 2024.APA
Oliveira, B. C. de, Marques, V. B., Brun, B. F., Silva, H. M. de O. e, Melo, S. F. S., Oliveira, E. M. de, et al. (2019). Dipeptidyl peptidase-4 inhibition prevents vascular dysfunction induced by β-adrenergic hyperactivity. Biomedicine & Pharmacotherapy, 113, 7 . doi:10.1016/j.biopha.2019.108733NLM
Oliveira BC de, Marques VB, Brun BF, Silva HM de O e, Melo SFS, Oliveira EM de, Santos L dos, Barauna VG. Dipeptidyl peptidase-4 inhibition prevents vascular dysfunction induced by β-adrenergic hyperactivity [Internet]. Biomedicine & Pharmacotherapy. 2019 ; 113 7 .[citado 2024 out. 21 ] Available from: https://doi.org/10.1016/j.biopha.2019.108733Vancouver
Oliveira BC de, Marques VB, Brun BF, Silva HM de O e, Melo SFS, Oliveira EM de, Santos L dos, Barauna VG. Dipeptidyl peptidase-4 inhibition prevents vascular dysfunction induced by β-adrenergic hyperactivity [Internet]. Biomedicine & Pharmacotherapy. 2019 ; 113 7 .[citado 2024 out. 21 ] Available from: https://doi.org/10.1016/j.biopha.2019.108733